Teva makes a positive economic impact in the countries in which we live and work. Through our spending and supply chain, we support jobs and contribute to gross domestic product (GDP). As a leading provider of generic medicines, our medicines contribute to significant healthcare savings around the world.
Based on independent analyses conducted by Matrix Global Advisors (MGA), Teva’s Global Economic Impact Report highlights Teva’s wide-ranging economic benefits and quantifies Teva’s direct and indirect economic impact in terms of jobs, labor income, GDP and generic drug savings.
Teva saved the US healthcare system $41.9 billion in 2018, supporting more than 57,300 jobs and contributing $15.0 billion to GDP.